A Japanese pharmaceutical company focused on the development and commercialization of prescription medicines, particularly in areas such as central nervous system disorders, immunology, and metabolic diseases. The firm operates globally through research partnerships and licensing arrangements, with ...
1 member of Congress has disclosed 1 trade in Mitsubishi Tanabe Pharma Corp ADR (MTPCY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-05-12 | PETER WELCH | buy | $1K – $15K |